Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Safety and feasibility of NeuroFlo use in eight- to 24-hour ischemic stroke patients.

Safety and feasibility of NeuroFlo use in eight- to 24-hour ischemic stroke patients. Int J Stroke. 2012 Dec; 7(8):655-61.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.